Botswana’s government announced the resumption of its mass COVID-19 vaccination campaign from Wednesday, August 18, as it seeks to inoculate more of its 2.3 million people.
The Southern African country recently received batches of the AstraZeneca and Johnson & Johnson vaccines and intends to use them to continue its Phase Two vaccination.
“Although phase two category covers adults aged 30 to 54 age groups, the target for now will be those aged 45 years and above, for purposes of managing congestions at vaccination sites,” a statement by the Permanent Secretary in the Health Ministry, Christopher Nyanga, said.
“Alongside those in the Phase two category as indicated, COVID-19 vaccination will also be administered on some frontline workers including security personnel, those in the mining sector and the teaching fraternity, amongst others,” the statement added.
By Tuesday, the Southern African country had fully vaccinated more than 161,000 people.
The country’s total number of COVID-19 infections stood at 142,380 with a death toll of 2,043.
The caseload has however seen a steady rise recently, prompting the government to announce tighter containment measures from this week, including the closure of schools, suspension of wedding ceremonies, reduced operating capacity for restaurants and a restriction n movement from 8p.m to 4a.m local time.